Cancer Letters
Volume 229, Issue 1 , Pages 59-65 , 8 November 2005

In vivo modification of adriamycin-induced apoptosis in L-5178Y lymphoma cell-bearing mice by (+)-α-tocopherol and superoxide dismutase

  • A. Bravo-Cuellar

      Affiliations

    • CUALTOS, Universidad de Guadalajara, Guadalajara, Jal. México
    • Corresponding Author InformationCorresponding author. Address: Centro de Investigación Biomédica de Occidente, IMSS, Sierra Mojada 800, Col. Independencia, CP 44340, Guadalajara, Jal. México. Tel.: +52 36 36189410; fax: +52 36 36181756.
  • ,
  • P.C. Gómez-Contreras

      Affiliations

    • Centro de Investigación Biomédica de Occidente, IMSS Guadalajara, Jal. México
  • ,
  • J.M. Lerma-Díaz

      Affiliations

    • Centro de Investigación Biomédica de Occidente, IMSS Guadalajara, Jal. México
  • ,
  • G. Hernández-Flores

      Affiliations

    • Centro de Investigación Biomédica de Occidente, IMSS Guadalajara, Jal. México
  • ,
  • J.R. Domínguez-Rodríguez

      Affiliations

    • Centro de Investigación Biomédica de Occidente, IMSS Guadalajara, Jal. México
  • ,
  • P. Ortíz-Lazareno

      Affiliations

    • Centro de Investigación Biomédica de Occidente, IMSS Guadalajara, Jal. México
  • ,
  • R. Cervantes-Munguia

      Affiliations

    • CUALTOS, Universidad de Guadalajara, Guadalajara, Jal. México
  • ,
  • S. Orbach-Arbouys

      Affiliations

    • Service de Pharmacie, Hôpital Paul-Brousse, Villejuif, France

Received 23 December 2004 ,Revised 10 January 2005 ,Accepted 17 January 2005.

References 

  1. Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu. Rev. Biochem. 2004;73:87–106
  2. Kukhta VK, Marozkina NV, Sokolchik IG, Bogaturova EV. Molecular mechanisms of apoptosis. Ukr. Biokhim. Zh. 2003;75:5–9
  3. Matassov D, Kagan T, Leblanc J, Sikorska M, Zakeri Z. Measurement of apoptosis by DNA fragmentation. Methods Mol. Biol. 2004;282:1–18
  4. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004;149:19–23
  5. Lovschall H, Mosekilde L. Apoptosis: cellular and clinical factors. Nord. Med. 1997;112:133–137
  6. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H2O2- and p53-dependent pathways. J. Biol. Chem. 2004;279:25535–25543
  7. Kumar D, Jugdutt BI. Apoptosis and oxidants in the heart. J. Lab. Clin. Med. 2003;142:288–297
  8. Muller I, Niethammer D, Bruchelt G. Antrhacycline derived chemotherapeutics in apoptosis and free radical cytotoxicity. Int. J. Mol. Med. 1988;1:491–494
  9. Beelen RHJ, Nibbering PH, Leenen PJM. The macrophage: basic and clinical aspects. Immunology. 1996;195:401–406
  10. Zaleskis G, Berleth E, Verstovsek S, Ehrke MJ, Mihich E. Doxorubicin-induced DNA degradation in murine thymocytes. Mol. Pharmacol. 1994;46:901–908
  11. Bravo-Cuellar A, Balercia G, Levesque JP, Liu XU, Osculati F, Orbach-Arbouys S. Enhanced activity of peritoneal macrophages after aclacinomycin injection: effects of the pre-treatment with superoxide dismutase on aclacinomycin-induced cytological alterations and antitumoral activity. Cancer Res. 1989;49:1576–1578
  12. Domínguez-Rodríguez JR, Gómez-Contreras PC, Hernández-Flores G, Lerma-Díaz JM, Carranco A, Cervantes-Munguia R, et al. In vivo inhibition by antioxidants of adriamycin-induced apoptosis in murine peritoneal macrophages. Anticancer Res. 2001;21:1869–1872
  13. R.W. Flo, A. Naess, F. Lund-Johansen, B.O. Maehle, H. Sjursen, V. Lehmann, C.O. Solberg, Negative selection of human monocytes using magnetic particles covered by anti-lymphocyte antibodies, J Immunol Methods 137 (1991) 89–94.
  14. Coligan JE, Kruisbeek M, Margulies DH, Shevac AM, Strober W. Morphological and biochemical assay of apoptosis. Curr. Protocols Immunol. 1992;17:1–16
  15. Gustincich S, Carminci P, Del Sal Mamtiotelli G, Schneider C. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991;11:256–260
  16. Plenchette S, Filomenko R, Logette E, Solier S, Buron N, Cathelin S, et al. Analyzing markers of apoptosis in vitro. Methods Mol. Biol. 2004;281:313–332
  17. Shankar S, Srivastava RK. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resist. Updat. 2004;7:139–156
  18. Rebbaa A, Zheng X, Chou PM, Mirkin BL. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene. 2003;22:2805–2811
  19. Muller I, Jenner A, Bruchelt G, Niethammer D, Halliwell B. Effect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage. Biochem. Biophys. Res. Commun. 1997;230:254–257
  20. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthraxcycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 1999;57:727–741
  21. Bravo-Cuellar A, Scott-Algara D, Metzger G, Orbach-Arbouys S. Enhanced activity of mouse peritoneal cells after aclacinomycin administration. Cancer Res. 1987;47:3477–3484
  22. Bravo-Cuellar A, Homo-Delarche F, Cabanes J, Orbach-Arbouys S. Enhanced activity of murine peritoneal cells after aclacinomycin injection: characteristics of the enhanced respiratory burst. Cancer Res. 1988;48:3440–3444
  23. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CI, Korsmeyer SJ. Bcl-2 fuctions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241–251
  24. Kawai K, Qin F, Shite J, Mao W, Fukuoka S, Liang CS. The importance of antioxidant and antiapoptotic effects of {beta}-receptor blockers in heart failure therapy. Am. J. Physiol. Heart Circ. Physiol. 2004;287:H1003–H1012
  25. Kobayashi D, Watanabe N, Sasaki H, Okamoto T, Tsuji N, Sato T, et al. Suppression of intracellular resistance factors by adriamycin augments heat-induced apoptosis via interleukin-1β-converting action in pancreatic carcinoma cells. Int. J. Cancer. 1998;76:552–555
  26. Mardones P, Rigotti A. Cellular mechanisms of vitamin E uptake: relevance in alpha-tocopherol metabolism and potential implications for disease. J. Nutr. Biochem. 2004;15:252–260
  27. Haddad JJ. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal. 2002;14:879–897
  28. Chiaramonte R, Bartolini E, Riso P, Calzavara E, Erba D, Testolin G, et al. Oxidative stress signalling in the apoptosis of Jurkat T-lymphocytes. J. Cell. Biochem. 2001;82:437–444

PII: S0304-3835(05)00068-6

doi: 10.1016/j.canlet.2005.01.013

Cancer Letters
Volume 229, Issue 1 , Pages 59-65 , 8 November 2005